M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial
Tabish Hazir,LeAnne M. Fox,Yasir Bin Nisar,Matthew P. Fox,Yusra Pervaiz Ashraf,William B. MacLeod,Afroze Ramzan,Sajid Maqbool,Tahir Masood,Waqar Hussain,Asifa Murtaza,Nadeem Khawar,Parveen Tariq,Rai Asghar,Jonathon L Simon,Donald M. Thea,Shamim Qazi +16 more
TL;DR: Home treatment with high-dose oral amoxicillin is equivalent to currently recommended hospitalisation and parenteral ampicillin for treatment of severe pneumonia without underlying complications, suggesting that WHO recommendations for treatment for severe pneumonia need to be revised.
Journal ArticleDOI
Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study
Christopher J. Gill,Grace Phiri-Mazala,Nicholas G Guerina,Joshua Kasimba,Charity Mulenga,William B. MacLeod,Nelson Waitolo,Anna B Knapp,Mark Mirochnick,Arthur Mazimba,Matthew P. Fox,Lora Sabin,Philip Seidenberg,Jonathon L Simon,Davidson H. Hamer +14 more
TL;DR: Training traditional birth attendants to manage common perinatal conditions significantly reduced neonatal mortality in a rural African setting and has high potential to be applied to similar settings with dispersed rural populations.
Journal ArticleDOI
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.
Dorita Avila,Keri N. Althoff,Catrina Mugglin,Kara Wools-Kaloustian,Manuel Koller,François Dabis,Denis Nash,Thomas Gsponer,Somnuek Sungkanuparph,Catherine C. McGowan,Margaret T May,David A. Cooper,Cleophas Chimbetete,Marcelo Wolff,Ann C. Collier,Hamish McManus,Mary-Ann Davies,Dominique Costagliola,Brenda Crabtree-Ramírez,Romanee Chaiwarith,Angela Cescon,Morna Cornell,Lameck Diero,Praphan Phanuphak,Adrien Sawadogo,Jochen Ehmer,Serge Eholié,Patrick C.K. Li,Matthew P. Fox,Neel R. Gandhi,Elsa González,Christopher K C Lee,Christopher J. Hoffmann,Andrew Kambugu,Olivia Keiser,Rossana Ditangco,Hans Prozesky,Fiona C Lampe,Nagalingeswaran Kumarasamy,Mari M. Kitahata,Emmanuel Lugina,Rita Lyamuya,Saphonn Vonthanak,Valeria Fink,Antonella d'Arminio Monforte,Paula M. Luz,Yi Ming Arthur Chen,Albert Minga,Jordi Casabona,Albert Mwango,Jun Yong Choi,Marie-Louise Newell,Elizabeth A. Bukusi,Kapella Zacharia Ngonyani,Tuti Parwati Merati,Juliana A. Otieno,Mwebesa B. Bosco,Sam Phiri,Oon T Ng,Kathryn Anastos,Jürgen K. Rockstroh,Ignacio Santos,Shinichi Oka,Geoffrey Somi,Christoph Stephan,Ramón Teira,Deo Wabwire,Gilles Wandeler,Andrew Boulle,Peter Reiss,Robin Wood,Benjamin H. Chi,Carolyn Williams,Jonathan A C Sterne,Matthias Egger +74 more
TL;DR: Median CD4 cell counts at the start of cART increased 2000–2009 but remained below 200 cells/&mgr;L in LIC and MIC and below 300 cells/ &mgr:L in HIC.
Journal ArticleDOI
Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa
Matthias Egger,Ben D. Spycher,John E. Sidle,Ralf Weigel,Elvin Geng,Matthew P. Fox,Patrick MacPhail,Gilles van Cutsem,Eugène Messou,Robin Wood,Denis Nash,Margaret Pascoe,Diana Dickinson,Jean-François Etard,James McIntyre,Martin W. G. Brinkhof,West Africa,Southern Africa +17 more
TL;DR: A nomogram and a web-based calculator are presented to correct estimates of program-level mortality for loss to follow-up, for use in antiretroviral treatment programs.
Journal ArticleDOI
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
Matthew P. Fox,Gilles van Cutsem,Janet Giddy,Mhairi Maskew,Mhairi Maskew,Olivia Keiser,Hans Prozesky,Robin Wood,Miguel A. Hernán,Miguel A. Hernán,Jonathan A C Sterne,Matthias Egger,Andrew Boulle +12 more
TL;DR: In resource-limited settings with viral load monitoring, virologic failure rates are highly sensitive to thresholds for confirmation, and there is considerable variability in switching failing patients, partially in response to immunologic status and postfailure evolution.